@article{AMJ4774,
author = {Andrew D. Gillen and Iain J. McEwan},
title = {Personalised treatment for prostate cancer patients: are we there yet?},
journal = {AME Medical Journal},
volume = {4},
number = {0},
year = {2019},
keywords = {},
abstract = {Prostate cancer (PCa) is an extremely heterogeneous disease—a small proportion of patients present with rapidly progressing, aggressive disease, referred to as unfavourable-risk PCa; whilst more commonly the disease progresses far more slowly and does not present an immediate health risk (1).},
issn = {2520-0518}, url = {https://amj.amegroups.org/article/view/4774}
}